Eurofins Scientific: stabilization phase

Covid. Eurofins is one of the few Cac40 stocks to have fallen since the start of the year. After the exponential growth phase known during the Covid, the return to normal is not easy to manage… Over the period 2020-2021, the company posted an exceptional increase in sales of +19% the first year and +24% the second. Revenue stabilized in 2022, which in itself is a good performance given the decline in activity linked to Covid. The core business related to bio-analysis has taken over, while it has posted an average increase of 6.5% per year over time…